From Molecule to Market: Rethinking the Role of MES in Pharma
What if the value of MES started before the first batch? Meet Siemens at Pharma MES Europe 2026 |1-2 October | Maritim proArte Hotel, Berlin
Bridging the gap between development and manufacturing remains a key challenge for pharmaceutical companies. Discover how next-generation MES connects process knowledge to manufacturing execution across the molecule-to-market digital thread.
MES is where process knowledge becomes manufacturing reality
Join Siemens at Pharma MES Europe 2026.
Time-to-market depends on how effectively knowledge moves from development to manufacturing. MES plays a critical role in the digital thread, transforming process knowledge into controlled manufacturing execution. Discover how Siemens is rethinking MES to help pharmaceutical manufacturers accelerate innovation and scale with confidence.
Join Siemens to explore how modern MES solutions help accelerate technology transfer, reduce complexity, connect IT and OT, and create the foundation for Industrial AI.
The challenges pharmaceutical manufacturers are solving today:
- Accelerating new product introduction
- Preventing knowledge loss during technology transfer
- Managing manufacturing complexity at scale
- Connecting IT and OT across operations
- Enabling Industrial AI with manufacturing context
- Modernizing MES while maintaining compliance
Modern. Connected. Pharmaceutical.
The next generation of MES for regulated manufacturing.
Attend the keynote, meet our experts, and discover how Siemens Opcenter helps connect the molecule-to-market journey.
Register here.